WEDNESDAY, Sept. 28, 2022 (HealthDay) — Japanese drugmaker Eisai on Wednesday said its experimental drug lecanemab helped slow thinking declines among people in the early stages of Alzheimer’s disease. The findings from a phase 3 clinical trial have yet to be peer-reviewed in any medical journal. But according to aContinue Reading

MONDAY, Sept. 26, 2022 (HealthDay News) — People who work in manufacturing, welding and chemical operations and are exposed to hazardous chemicals may face a higher risk of developing amyotrophic lateral sclerosis (ALS), a new study found. “This study shows that certain occupational settings and exposures increase one’s chances ofContinue Reading

THURSDAY, Sept. 22, 2022 (HealthDay News) — Climate change could spell trouble for those with heart failure, a new study suggests. When the temperatures soared in France during the summer of 2019, the heat wave appears to have worsened the conditions of heart failure patients, researchers report. “The finding isContinue Reading

WEDNESDAY, Sept. 21, 2022 (HealthDay News) — Your children’s school clothes may look neat, but are they safe to wear? Maybe not. Researchers found high levels of dangerous chemicals called per- and polyfluoroalkyl substances (PFAS) in school uniforms sold across North America. These chemicals — which can build up inContinue Reading